Health Catalyst (NASDAQ:HCAT) Share Price Breaks Above Two Hundred Day Moving Average – Here’s What Happened

Health Catalyst, Inc. (NASDAQ:HCAT)’s share price passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $1.73 and traded as high as $1.8350. Health Catalyst shares last traded at $1.80, with a volume of 695,473 shares traded.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on HCAT. Weiss Ratings restated a “sell (d-)” rating on shares of Health Catalyst in a report on Monday. Canaccord Genuity Group downgraded shares of Health Catalyst from a “buy” rating to a “hold” rating and reduced their price target for the company from $3.00 to $1.80 in a report on Thursday, August 20th. Citigroup lowered their price target on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 11th. Finally, Wells Fargo & Company dropped their price objective on shares of Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating for the company in a research note on Thursday, August 13th. Two analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $2.01.

Health Catalyst Trading Down 5.6%

The company has a debt-to-equity ratio of 1.51, a current ratio of 2.70 and a quick ratio of 2.70. The company has a 50-day moving average price of $1.72 and a 200-day moving average price of $1.72.

Health Catalyst (NASDAQ:HCAT) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. Health Catalyst had a negative return on equity of 1.83% and a negative net margin of 90.61%. The firm had revenue of $70.49 million during the quarter, compared to analysts’ expectations of $69.09 million. On average, equities analysts anticipate that Health Catalyst, Inc. will post -0.18 EPS for the current fiscal year.

Insider Buying and Selling

In other Health Catalyst news, CEO Simeon Kohl purchased 59,000 shares of the business’s stock in a transaction on Monday, September 14th. The stock was bought at an average cost of $1.79 per share, for a total transaction of $105,610.00. Following the acquisition, the chief executive officer owned 2,856,385 shares of the company’s stock, valued at approximately $5,112,929.15. The trade was a 2.11% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 19.40% of the company’s stock.

Institutional Investors Weigh In On Health Catalyst

Institutional investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new position in Health Catalyst in the second quarter valued at $3,654,000. Hsbc Holdings PLC increased its stake in Health Catalyst by 313.3% during the second quarter. Hsbc Holdings PLC now owns 408,634 shares of the company’s stock worth $809,000 after acquiring an additional 309,766 shares during the last quarter. Palogic Value Management L.P. acquired a new stake in Health Catalyst during the second quarter worth about $9,796,000. Squarepoint Ops LLC raised its holdings in shares of Health Catalyst by 1,214.8% in the 2nd quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock worth $796,000 after purchasing an additional 369,772 shares during the period. Finally, Deutsche Bank AG purchased a new position in shares of Health Catalyst in the 2nd quarter worth about $43,000. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

About Health Catalyst

Health Catalyst, Inc is a healthcare technology company that provides data and analytics solutions to help healthcare organizations improve clinical outcomes, operational efficiency and financial performance. Its customers include hospitals, health systems, medical groups and other healthcare organizations seeking to integrate and analyze data from across their operations.

The company’s offerings are built around its Health Catalyst Data Operating System, a cloud-based platform designed to combine information from electronic health records, financial systems and other sources.